Posts in Success story
Empowering digital transformation at L'Oréal with Discngine Assay cloud solution

Digital technologies are reshaping the landscape of discovery and innovation. L’Oréal has been leading the charge in embracing digital transformation and data-driven processes. Collaborating with Discngine, they've successfully migrated multiple of their scientific software applications to the cloud, enhancing research and innovation. Join us as we hear from project leaders Ludwig Baux and Diane Genest about their journey of migrating the screening assay data management software at L’Oréal.

Read More
How Sanofi scientists streamlined their in silico hazard assessment of potential genotoxic impurities by collaborating with Discngine

Sanofi assesses over 1000 potentially mutagenic or genotoxic impurities per year. Until recently, these assessments used to imply a lot of manual operations from its scientists. Alexander Amberg, Head of in silico toxicology, and Alain Grelier, Digital product owner, shared how we collaborated to drastically streamline the in silico hazard assessment of these impurities.

Read More
Shifting to the Cloud: the story of a French biotech startup

Cloud environment can bring a lot of benefits, to research-driven organizations, but shifting from an on-premises (local) to a Cloud environment can be challenging and sometimes scary. This article will outline an example of a French Biotech Startup that migrated its scientific software applications toolset to the Cloud and reveal the real-life advantages of this migration that exceeded expectations.

Read More
An innovative way of organizing data: How can 3decision® improve decision-making process? [Customer Success Story]

Manuel Cases Thomas, a Medicinal chemistry consultant and director at Senechaem was looking for a solution to help him use the full potential of data at hand and generate new design ideas. In this interview, he shares how 3decision® makes a difference in his daily work: from a scientific need to the impact on design ideas and successful project outcomes.

Read More
What are the challenges for medicinal chemists when working with 3D structures? - Interview

The continuous increase in the available 3D structural data brings along changes in the medicinal chemistry field. Dr. George Sheppard, Senior Principal Research Scientist at AbbVie, shared his thoughts on the benefits for medicinal chemists using 3D information, current challenges and limitations, and proposed potential ways for improvement, in the following interview.

Read More